Info@ThinkPinkRocks.com

Angiotensin system inhibitor use improves metastatic RCC survival outcomes

Use of angiotensin system inhibitors is associated with significant survival benefits in metastatic renal cell carcinoma patients treated in the targeted therapy era, research findings indicate.

Follow this link:
Angiotensin system inhibitor use improves metastatic RCC survival outcomes

Share

Leave a Reply

Solve : *
28 − 15 =